Prognostic and Predictive Biomarkers in Recurrent WHO Grade 3 Glioma Patients Treated with Bevacizumab and Irinotecan

Original languageEnglish
Publication date2016
DOIs
Publication statusPublished - 2016
EventDansk Patologiselskab: Anvendt molekylærpatologi - Scandic Hotel, København
Duration: 10 Mar 201612 Mar 2016

Conference

ConferenceDansk Patologiselskab
LocationScandic Hotel, København
Period10/03/201612/03/2016

Cite this